The Board of Appeal of the European Patent Office recently adopted a ruling related to the so-called WARF/Thomson stem cell application.
This patent application describes a method to obtain embryonic stem cell cultures from primates, including humans, and was filed by the Wisconsin Alumni Research Foundation in 1995.
The Board of Appela has decided that under the European Patent Convention it is not possible to grant a patent for an invention that requires the use and destruction of human embryos.
This patent application describes a method to obtain embryonic stem cell cultures from primates, including humans, and was filed by the Wisconsin Alumni Research Foundation in 1995.
The Board of Appela has decided that under the European Patent Convention it is not possible to grant a patent for an invention that requires the use and destruction of human embryos.
The Board stressed, however, that its decision does not concern the general question of human stem cell patentability.
Nessun commento:
Posta un commento